About this trial
This study systematically observes in a pragmatic trail under real world conditions the association between strategies of therapy (maximal therapy, withhold, withdraw) and treatment success in three endpoint related initial risk groups (high, intermediate, low risk) regarding three endpoints (burden, mortality and supply costs).
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
All patients dying on the ICU and all patients staying for at least 72 hours on the ICU
Disqualifiers
No
Trial population
Critically ill patients admitted to the intensive care unit, mainly surgical and polytraumatized patients
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Burden of care
Organ dysfunctions supported or replaced in numbers
Mortality
Dying patients in numbers
Supply costs
Costs in sum of Simplified Acute Physiology Score (SAPS) II score points over ICU stay; Costs in sum of points of organ support over ICU stay; Costs in Euro reimbursed for the ICU stay
Sponsors and contacts
Click on the lead sponsor to view all of their trials.